65,437 trials
Type2 Diabetes · Diabetes Mellitus · Diabetes Mellitus, Type 2
Primary: Change From Baseline in Hemoglobin A1c (HbA1c) (Pooled Doses of Tirzepatide 5 mg and 10 mg) — -2.03; -0.23 percentage of HbA1c — p=<0.001
Intracranial Aneurysm
Primary: Prognostic Value of the MAFA (Mean Aneurysm Flow Amplitude) Ratio With Respect to Full Aneurysm Occlusion Within 12 Months — 0.540 probability
Attentional Bias · Smoking Cues · Positive Perceptions About Cigarette Smoking
Primary: Implicit Positive Smoking Expectancies, Measured by the Implicit Association Test — 1072.96; 1029.87 milliseconds
Breast Biopsy
Primary: Impact of US-guided DOT on the Potential Reduction of Benign Biopsies as Measured by Comparing the Reads With a Non- Suspicious Assessment of Conventional Imaging (CI)…
Non-small Cell Lung Cancer (NSCLC)
Primary: Feasibility of Calypso Transponders — 46; 2 Participants
Knowledge, Attitudes, Practice
Primary: Provider Participant Recruitment Rates (Feasibility of Conducting a Larger Trial) — 93 Participants
Lung Cancer Metastatic · NSCLC Stage IV · Adenocarcinoma of Lung
Primary: Objective Response Rate (ORR) — 10; 0; 0; 10 Participants
Chronic Heart Failure With Reduced Ejection Fraction
Primary: Treatment Tolerability: Number of Participants Without Discontinuation of Study Intervention (Incl. Max. 1 Day Interruption) and Without Moderate to Severe Symptomatic…
Respiratory Syncytial Virus (RSV)
Primary: Geometric Mean Titer (GMT) of Serum Neutralizing Titers (NTs) for Respiratory Syncytial Virus Subgroup A (RSV A) and Respiratory Syncytial Virus Subgroup B (RSV B)…
Myocardial Infarction · No-Reflow Phenomenon
Primary: Hospital Mortality Rate — 6; 2 Participants
Chronic Rhinosinusitis With Nasal Polyps
Primary: Change From Baseline in Nasal Polyps Score at Week 24 — -0.50; -2.34 score on a scale — p=<0.0001
Respiratory Syncytial Virus Infections
Primary: Part A: RSV-A Neutralizing Titers Expressed as Group Geometric Mean Titers (GMTs) — 11910.1; 8593.6 Titer
Breast Carcinoma
Primary: Average Nausea Defined as the Average [ MAXIMUM ] Nausea Rating Across 15 Assessment Points at Cycle 1 and 16 Assessment Points at Cycle 2 (Comparing Prochlorperazine or…
Cancer · Thoracic Neoplasms · Gastrointestinal Cancer
Primary: Participants With Change in Their Physician-assessed Burden Score — 43; 32; 25 Participants
Zika Virus
Primary: Number of Participants With Solicited Local and Systemic Reactogenicity Adverse Reactions (ARs) — 86; 164; 183; 163 Participants